Compounds > piperacillin--tazobactam-drug-combination

piperacillin--tazobactam-drug-combination and Liver-Diseases

piperacillin--tazobactam-drug-combination has been researched along with Liver-Diseases* in 1 studies

Other Studies

1 other study(ies) available for piperacillin--tazobactam-drug-combination and Liver-Diseases

Article	Year
Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam. Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:11 Piperacillin/tazobactam (TZP) is a commonly prescribed antibiotic. Here, we report a patient who developed agranulocytosis, thrombocytopenia, and severe hepatic dysfunction on day 17 while receiving TZP treatment for an intracranial infection. Bone marrow suppression and hepatic dysfunction are serious adverse effects that should be kept in mind when using long-term TZP. Topics: Adult; Agranulocytosis; Bone Marrow; Humans; Liver; Liver Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia	2013

Article

Year

Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.

Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:11

Piperacillin/tazobactam (TZP) is a commonly prescribed antibiotic. Here, we report a patient who developed agranulocytosis, thrombocytopenia, and severe hepatic dysfunction on day 17 while receiving TZP treatment for an intracranial infection. Bone marrow suppression and hepatic dysfunction are serious adverse effects that should be kept in mind when using long-term TZP.

Topics: Adult; Agranulocytosis; Bone Marrow; Humans; Liver; Liver Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia

2013